{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:55:54Z","timestamp":1777478154316,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T00:00:00Z","timestamp":1281916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10354-010-0814-1","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T08:52:48Z","timestamp":1281948768000},"page":"600-604","source":"Crossref","is-referenced-by-count":20,"title":["Laboratory and genetic evaluation of Gaucher disease","Labordiagnostik bei Morbus Gaucher"],"prefix":"10.1007","volume":"160","author":[{"given":"Olaf A.","family":"Bodamer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"814_CR1","first-page":"3635","volume-title":"The metabolic and molecular basis of inherited disease","author":"E Beutler","year":"2001","unstructured":"Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (eds) The metabolic and molecular basis of inherited disease, Vol. II. McGraw-Hill, Columbus, USA, pp 3635\u20133668, 2001"},{"key":"814_CR2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak M, Futerman AH. Gaucher disease: pathological mechanisms and modern management. Br J Haemat, 129: 178\u2013188, 2005","journal-title":"Br J Haemat"},{"key":"814_CR3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","volume":"72","author":"A Tylki-Szymanska","year":"2007","unstructured":"Tylki-Szymanska A, Czartoryska B, Vanier MT, et al. Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin Genet, 72: 538\u2013542, 2007","journal-title":"Clin Genet"},{"key":"814_CR4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1542\/peds.2008-0635","volume":"123","author":"O Staretz-Chacham","year":"2009","unstructured":"Staretz-Chacham O, Lang TC, LaMarca ME, et al. Lysosomal storage disorders in the newborn. Pediatrics, 123: 1191\u20131207, 2009","journal-title":"Pediatrics"},{"key":"814_CR5","first-page":"97","volume":"38","author":"MC Sa Miranda","year":"1990","unstructured":"Sa Miranda MC, Aerts JM, Pinto R, et al. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients. Clin Genet, 38: 97\u201399, 1990","journal-title":"Clin Genet"},{"key":"814_CR6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj3030377","volume":"303","author":"I Meivar-Levy","year":"1994","unstructured":"Meivar-Levy I, Horowitz M, Futerman AH. Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. Biochem J, 303: 377\u2013382, 1994","journal-title":"Biochem J"},{"key":"814_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1079-9796(03)00010-X","volume":"30","author":"B Rudensky","year":"2003","unstructured":"Rudensky B, Paz E, Altarescu G, et al. Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease. Blood Cells Mol Dis, 30: 97\u201399, 2003","journal-title":"Blood Cells Mol Dis"},{"key":"814_CR8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","volume":"50","author":"Y Li","year":"2004","unstructured":"Li Y, Scott CR, Chamoles NA, et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem, 50: 1785\u20131796, 2004","journal-title":"Clin Chem"},{"key":"814_CR9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","volume":"54","author":"XK Zhang","year":"2008","unstructured":"Zhang XK, Elbin CS, Chuang WL, et al. Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin Chem, 54: 1725\u20131728, 2008","journal-title":"Clin Chem"},{"key":"814_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jmg.25.5.322","volume":"25","author":"FY Choy","year":"1988","unstructured":"Choy FY. Intrafamilial clinical variability of type 1 Gaucher disease in a French-Canadian family. J Med Genet, 25: 322\u2013325, 1988","journal-title":"J Med Genet"},{"key":"814_CR11","first-page":"205","volume":"10","author":"V Barak","year":"1999","unstructured":"Barak V, Acker M, Nisman B, et al. Cytokines in Gaucher's disease. Europ Cytokine Netw, 10: 205\u2013210, 1999","journal-title":"Europ Cytokine Netw"},{"key":"814_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","volume":"23","author":"CE Hollak","year":"1997","unstructured":"Hollak CE, Evers L, Aerts JM, et al. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis, 23: 201\u2013212, 1997","journal-title":"Blood Cells Mol Dis"},{"key":"814_CR13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, VanWeely S, Van Oers MH, et al. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest, 93: 1288\u20131292, 1994","journal-title":"J Clin Invest"},{"key":"814_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","volume":"381","author":"A Schoonhoven","year":"2007","unstructured":"Schoonhoven A, Rudensky B, Elstein D, et al. Monitoring of Gaucher patients with a novel chitotriosidase assay. Clin Chim Acta, 381: 136\u2013139, 2007","journal-title":"Clin Chim Acta"},{"key":"814_CR15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1534\/genetics.107.075846","volume":"177","author":"AP Bussink","year":"2007","unstructured":"Bussink AP, Speijer D, Aerts JM, et al. Evolution of mammalian chitinase (-like) members of family 18 glycosyl hydrolases. Genetics, 177: 959\u2013970, 2007","journal-title":"Genetics"},{"key":"814_CR16","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","volume":"273","author":"RG Boot","year":"1998","unstructured":"Boot RG, Renkema GH, Verhoek M, et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem, 273: 25680\u201325685, 1998","journal-title":"J Biol Chem"},{"key":"814_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","volume":"103","author":"RG Boot","year":"2004","unstructured":"Boot RG, Verhoek M, de Fost M, et al. Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood, 103: 33\u201339, 2004","journal-title":"Blood"},{"key":"814_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","volume":"35","author":"PB Deegan","year":"2005","unstructured":"Deegan PB, Moran MT, Farlane IM, et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis, 35: 259\u2013267, 2005","journal-title":"Blood Cells Mol Dis"},{"key":"814_CR19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s10545-006-0318-8","volume":"29","author":"RG Boot","year":"2006","unstructured":"Boot RG, Verhoek M, Langeveld M, et al. CCL18: a urinary marker of Gaucher cell burden in Gaucher patients. J Inherit Metab Dis, 29: 564\u2013571, 2006","journal-title":"J Inherit Metab Dis"},{"key":"814_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbalip.2007.11.004","volume":"1781","author":"JE Groener","year":"2008","unstructured":"Groener JE, Poorthuis BJ, Kuiper S, et al. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: Correlations with disease severity and response to therapeutic intervention. Biochim Biophys, 1781: 72\u201378, 2008","journal-title":"Biochim Biophys"},{"issue":"Suppl 2","key":"814_CR21","first-page":"106","volume":"24","author":"TM Cox","year":"2001","unstructured":"Cox TM. Gaucher disease. Understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis, 24(Suppl 2): 106\u2013121, 2001","journal-title":"J Inherit Metab Dis"},{"key":"814_CR22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bcmd.2007.10.004","volume":"40","author":"PJ Meikle","year":"2008","unstructured":"Meikle PJ, Whitfield PD, Rozaklis T, et al. Plasma lipids are altered in Gaucher disease: Biochemical markeres to evaluate therapeutic intervention. Blood Cells Mol Dis, 40: 420\u2013427, 2008","journal-title":"Blood Cells Mol Dis"},{"key":"814_CR23","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/bmj.286.6381.1864","volume":"286","author":"MA Morgan","year":"1983","unstructured":"Morgan MA, Hoffbrand AV, Laulicht M, et al. Serum ferritin concentration in Gaucher's disease. Br Med J, 286: 1864, 1983","journal-title":"Br Med J"},{"key":"814_CR24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2004.02.018","volume":"344","author":"MA Cabrera-Salazar","year":"2004","unstructured":"Cabrera-Salazar MA, O'Rourke E, Henderson N, et al. Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy. Clin Chim Acta, 344: 101\u2013107, 2004","journal-title":"Clin Chim Acta"},{"key":"814_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10545-005-0585-9","volume":"4","author":"A Vellodi","year":"2005","unstructured":"Vellodi A, Foo Y, Cole TJ. Evaluation of three biochemical markers in the monitoring of Gaucher disease. J Inher Metab Dis, 4: 585\u2013592, 2005","journal-title":"J Inher Metab Dis"},{"key":"814_CR26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J, et al. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol, 65: 1353\u20131357, 2008","journal-title":"Arch Neurol"},{"key":"814_CR27","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerbrosidase mutations in Parkinson's diseases. New Engl J Med, 361: 1651\u20131661, 2009","journal-title":"New Engl J Med"},{"key":"814_CR28","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.82.21.7289","volume":"82","author":"J Sorge","year":"1985","unstructured":"Sorge J, West C, Westwood B, et al. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci USA, 82: 7289\u20137293, 1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"814_CR29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00279398","volume":"64","author":"RA Barneveld","year":"1983","unstructured":"Barneveld RA, Keijzer W, Tegelaers FP, et al. Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies. Hum Genet, 64: 227\u2013231, 1983","journal-title":"Hum Genet"},{"key":"814_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","volume":"4","author":"M Horowitz","year":"1989","unstructured":"Horowitz M, Wilder S, Horowitz Z, et al. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics, 4: 87\u201396, 1989","journal-title":"Genomics"},{"key":"814_CR31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat, 29: 567\u2013583, 2008","journal-title":"Hum Mutat"},{"key":"814_CR32","first-page":"79","volume":"47","author":"T Latham","year":"1990","unstructured":"Latham T, Grabowski GA, Theophilus BD, et al. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet, 47: 79\u201386, 1990","journal-title":"Am J Hum Genet"},{"key":"814_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI114415","volume":"85","author":"A Zimran","year":"1990","unstructured":"Zimran A, Sorge J, Gross E, Kubitz M, et al. Glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. J Clin Invest, 85: 219\u2013222, 1990","journal-title":"J Clin Invest"},{"key":"814_CR34","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","volume":"42","author":"O Goker-Alpan","year":"2005","unstructured":"Goker-Alpan O, Hruska KS, Orvisky E, et al. Divergent phenotypes in Gaucher disease implicate the role of modifiers. J Med Genet, 42: e37, 2005","journal-title":"J Med Genet"},{"key":"814_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","volume":"97","author":"RH Lachmann","year":"2004","unstructured":"Lachmann RH, Grant IR, Halsall D, et al. Twin pairs showing discordance of phenotype in adult Gaucher's disease. Quart J Med, 97: 199\u2013204, 2004","journal-title":"Quart J Med"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0814-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-010-0814-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0814-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:03:53Z","timestamp":1559145833000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-010-0814-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":35,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1007\/s10354-010-0814-1","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,16]]}}}